1. Home
  2. XRX vs STRO Comparison

XRX vs STRO Comparison

Compare XRX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xerox Holdings Corporation

XRX

Xerox Holdings Corporation

HOLD

Current Price

$3.26

Market Cap

368.8M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$25.55

Market Cap

381.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRX
STRO
Founded
1906
2003
Country
United States
United States
Employees
N/A
133
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.8M
381.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
XRX
STRO
Price
$3.26
$25.55
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$2.50
$31.33
AVG Volume (30 Days)
3.7M
238.8K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
6.31%
N/A
EPS Growth
23.26
N/A
EPS
N/A
N/A
Revenue
$117,000,000.00
N/A
Revenue This Year
$8.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$0.72
52 Week High
$4.42
$43.85

Technical Indicators

Market Signals
Indicator
XRX
STRO
Relative Strength Index (RSI) 57.71 42.84
Support Level $2.40 $23.53
Resistance Level $3.74 $27.96
Average True Range (ATR) 0.25 1.59
MACD 0.06 0.28
Stochastic Oscillator 55.91 52.48

Price Performance

Historical Comparison
XRX
STRO

About XRX Xerox Holdings Corporation

Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: